中国临床药理学与治疗学2024,Vol.29Issue(5) :495-500.DOI:10.12092/j.issn.1009-2501.2024.05.003

1例烟雾病合并子宫内膜异位症患者围手术期抗血小板药物调整及术后预防内异症复发药物选择的病例分析

A case analysis of medication adjustments on a moyamoya disease patient with endometriosis by DAPT treatment during perioperative period and formulation of DIE postoperative recurrence prevention

罗莉婷 金经
中国临床药理学与治疗学2024,Vol.29Issue(5) :495-500.DOI:10.12092/j.issn.1009-2501.2024.05.003

1例烟雾病合并子宫内膜异位症患者围手术期抗血小板药物调整及术后预防内异症复发药物选择的病例分析

A case analysis of medication adjustments on a moyamoya disease patient with endometriosis by DAPT treatment during perioperative period and formulation of DIE postoperative recurrence prevention

罗莉婷 1金经2
扫码查看

作者信息

  • 1. 复旦大学附属妇产科医院药学部,上海 200090;珠海市妇幼保健院药学部,珠海 519000,广东
  • 2. 复旦大学附属妇产科医院药学部,上海 200090
  • 折叠

摘要

目的:探讨临床药师在烟雾病患者围术期个体化治疗与用药监护中的工作要点.方法:参与1例烟雾病合并子宫内膜异位症患者围术期双联抗血小板治疗的药物调整、围术期应用质子泵抑制剂及深部子宫内膜异位症术后预防复发方案的制订与用药监护.结果:通过对患者的个体化评估确定符合患者的双联抗血小板治疗在围术期停药方案,制订个体化的围术期应用质子泵抑制剂及深部子宫内膜异位症术后预防复发方案.结论:个体化用药方案的制订及用药监护是临床药师开展药学服务的切入点.

Abstract

AIM:To explore the key points of per-sonalized treatment and medication monitoring by clinical pharmacists in the perioperative period of moyamoya disease patients with endometriosis.METHODS:This study showed a moyamoya disease patient with endometriosis who accepting dual an-tiplatelet therapy and how to adjust medication during the perioperative period.Besides,monitor-ing the use proton pump inhibitors in the perioper-ative period and the formulating a plan of DIE post-operative recurrence prevention are also our objec-tives.RESULTS:Through individualized assessment of the patient,a personalized medication adjust-ments for dual antiplatelet therapy was deter-mined.Individualized perioperative proton pump inhibitor regimen and postoperative prevention plan for endometriosis recurrence were developed.CONCLUSION:The development of individualized medication regimens and medication monitoring is the breakthrough point for clinical pharmacists to carry out pharmaceutical services.

关键词

烟雾病/子宫内膜异位症/双联抗血小板/预防复发

Key words

moyamoya disease/endometriosis/DAPT/preventing recurrence

引用本文复制引用

基金项目

上海市"医苑新星"青年医学人才培养项目(2021)(076478684Q/2022-00033)

出版年

2024
中国临床药理学与治疗学
中国药理学会

中国临床药理学与治疗学

CSTPCD北大核心
影响因子:0.97
ISSN:1009-2501
参考文献量20
段落导航相关论文